Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
$2.8M Buy
99,842
+6,842
+7% +$192K ﹤0.01% 1362
2016
Q3
$2.55M Buy
93,000
+1,438
+2% +$39.5K ﹤0.01% 1369
2016
Q2
$2M Buy
91,562
+11,458
+14% +$250K ﹤0.01% 1428
2016
Q1
$1.79M Buy
80,104
+1,251
+2% +$28K ﹤0.01% 1472
2015
Q4
$2.18M Buy
78,853
+60,284
+325% +$1.67M ﹤0.01% 1380
2015
Q3
$479K Buy
18,569
+18,312
+7,125% +$472K ﹤0.01% 2221
2015
Q2
$6K Buy
+257
New +$6K ﹤0.01% 3664

Other funds holding QGENF

BlackRock Advisors's QGENF Position: Q4 2016 in Review

BlackRock Advisors increased its QIAGEN NV (QGENF) stake by 7.4% in Q4 2016, buying an estimated $192K and bringing the position to 99,842 shares worth $2.8M. The position accounts for ﹤0.01% of the portfolio, ranked #1362.

BlackRock Advisors first reported a position in QGENF in Q2 2015 and has held it in 7 quarters since. 189 funds tracked by Wall St. Rank hold QGENF as of Q4 2016.

  • BlackRock Advisors held 99,842 shares of QIAGEN NV worth $2.8M as of Q4 2016.
  • BlackRock Advisors bought 6,842 QIAGEN NV shares in Q4 2016, an estimated $192K.
  • QIAGEN NV made up ﹤0.01% of BlackRock Advisors's portfolio in Q4 2016, its #1362 holding.
  • BlackRock Advisors first reported a position in QIAGEN NV in Q2 2015 and has held it in 7 quarters since.
  • 189 funds tracked by Wall St. Rank held QIAGEN NV as of Q4 2016.

Based on BlackRock Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.